Phase II study of reintroduction of oxaliplatin for advanced colorectal cancer in patients previously treated with oxaliplatin and irinotecan: RE-OPEN study - Suenaga, M; Mizunuma, N; Matsusaka, S (Drug Des Devel Ther, 2015)